Snowden Capital Advisors LLC Trims Stock Holdings in The Clorox Company (NYSE:CLX)

Snowden Capital Advisors LLC lowered its holdings in The Clorox Company (NYSE:CLX) by 7.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,585 shares of the company’s stock after selling 195 shares during the period. Snowden Capital Advisors LLC’s holdings in Clorox were worth $420,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Integral Investment Advisors Inc. boosted its holdings in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after purchasing an additional 67 shares during the last quarter. Sound View Wealth Advisors Group LLC boosted its holdings in Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after purchasing an additional 77 shares during the last quarter. Wedbush Securities Inc. boosted its holdings in Clorox by 1.2% in the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock valued at $1,238,000 after purchasing an additional 94 shares during the last quarter. Global X Japan Co. Ltd. boosted its holdings in Clorox by 3.0% in the fourth quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company’s stock valued at $531,000 after purchasing an additional 95 shares during the last quarter. Finally, Aviance Capital Partners LLC raised its stake in Clorox by 3.2% during the fourth quarter. Aviance Capital Partners LLC now owns 3,180 shares of the company’s stock valued at $516,000 after buying an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the transaction, the director now directly owns 4,000 shares in the company, valued at $546,280. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Wells Fargo & Company cut their price objective on Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Citigroup cut their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. Evercore ISI set a $140.00 price objective on Clorox and gave the company an “underperform” rating in a research note on Tuesday, May 6th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, Barclays cut their price objective on Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $151.23.

Clorox Stock Down 2.7%

Shares of Clorox stock opened at $131.90 on Thursday. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $16.26 billion, a price-to-earnings ratio of 36.04, a PEG ratio of 2.62 and a beta of 0.60. The business’s 50 day simple moving average is $140.26 and its 200-day simple moving average is $152.82.

Clorox (NYSE:CLX) last posted its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the business earned $1.71 earnings per share. The firm’s revenue was down 8.0% compared to the same quarter last year. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.70%. The ex-dividend date of this dividend was Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 87.61%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.